Petaluma, CA, United States of America

Jason Carbol

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason Carbol: Innovator in Topical Pharmaceutical Compositions

Introduction

Jason Carbol is a notable inventor based in Petaluma, California. He has made significant contributions to the field of pharmaceuticals, particularly in developing topical compositions for dermatological applications. His innovative work has led to the filing of a patent that addresses various skin disorders.

Latest Patents

Jason Carbol holds a patent for a topical pharmaceutical composition comprising 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile. This patent discloses compositions intended for application to the skin, along with methods for their preparation and use in treating dermatological disorders. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Jason Carbol is currently associated with Principia Biopharma Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry.

Collaborations

Jason collaborates with talented professionals in his field, including Katherine A. Chu and Jyoti Wadhwa. These partnerships enhance the research and development process, leading to more effective pharmaceutical solutions.

Conclusion

In summary, Jason Carbol is a dedicated inventor whose work in topical pharmaceutical compositions has the potential to significantly impact dermatological treatments. His contributions to the field are noteworthy, and his ongoing efforts at Principia Biopharma Inc. continue to drive innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…